MBMA
Dnr:
NAISS 2023/22-1130
Type:
NAISS Small Compute
Principal Investigator:
Maria Kjellsson
Affiliation:
Uppsala universitet
Start Date:
2023-11-23
End Date:
2025-01-01
Primary Classification:
30101: Pharmaceutical Sciences
Allocation
- Klemming at PDC: 500 GiB
- Crex 1 at UPPMAX: 128 GiB
- Rackham at UPPMAX: 5 x 1000 core-h/month
- Dardel at PDC: 5 x 1000 core-h/month
Abstract
This project is a pharmacometic project focusing on model-based meta analysis (MBMA) combining summary-level data with individual level data for longitudinal modelling.